LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.73 | 84.90 | 315 | 3254 | 0.0968 | 0.2831 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.73 | 84.90 | 3315 | 3254 | 1.0186 | 1.0070 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.73 | 84.90 | 355 | 3254 | 0.1091 | 0.3125 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.73 | 84.90 | 3326 | 3254 | 1.0220 | 1.0083 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 38.43 | 84.90 | 407 | 3459 | 0.1176 | 0.3405 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 38.43 | 84.90 | 3518 | 3459 | 1.0169 | 1.0063 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 38.43 | 84.90 | 406 | 3459 | 0.1174 | 0.3399 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 38.43 | 84.90 | 3550 | 3459 | 1.0261 | 1.0097 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 40.14 | 84.90 | 376 | 3682 | 0.1021 | 0.3147 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 40.14 | 84.90 | 3747 | 3682 | 1.0176 | 1.0064 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 40.14 | 84.90 | 441 | 3682 | 0.1198 | 0.3538 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 40.14 | 84.90 | 3786 | 3682 | 1.0282 | 1.0103 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.84 | 84.90 | 436 | 4003 | 0.1089 | 0.3422 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.84 | 84.90 | 4061 | 4003 | 1.0145 | 1.0052 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.84 | 84.90 | 435 | 4003 | 0.1087 | 0.3417 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 41.84 | 84.90 | 3991 | 4003 | 0.9970 | 0.9989 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 43.55 | 84.90 | 433 | 4287 | 0.1010 | 0.3337 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 43.55 | 84.90 | 4246 | 4287 | 0.9902 | 0.9965 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 43.55 | 84.90 | 431 | 4287 | 0.1005 | 0.3326 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 43.55 | 84.90 | 4299 | 4287 | 1.0026 | 1.0009 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 45.25 | 84.90 | 479 | 4539 | 0.1055 | 0.3518 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 45.25 | 84.90 | 4561 | 4539 | 1.0047 | 1.0016 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 45.25 | 84.90 | 492 | 4539 | 0.1084 | 0.3581 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 45.25 | 84.90 | 4534 | 4539 | 0.9987 | 0.9996 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 46.95 | 84.90 | 528 | 4952 | 0.1066 | 0.3655 | MN20160318_Q02 | L17 |